Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Zhonghua Nan Ke Xue ; 23(4): 353-360, 2017 Apr.
Article in Chinese | MEDLINE | ID: mdl-29714422

ABSTRACT

OBJECTIVE: To explore the effects of Kudzu Root plus Cinnamon Granules (KR+C) on prostatic hyperplasia (PH) in mice. METHODS: Sixty 4-week-old Kunming male mice were randomly divided into six groups: blank control, PH model, high-, medium- and low-dose KR+C, and finasteride control. All the mice except those in the blank control group were subcutaneously injected with testosterone propionate (5 mg / ï¼»kg·dï¼½) at 7 days after surgical castration. The animals of different groups were treated intragastrically with different doses of KR+C, finasteride, and normal saline respectively for 3 weeks and then sacrificed for weighing of the prostate, calculation of the prostatic index, observation of the morphological changes in the prostate after HE staining, determination of the expressions of FGF2, Ki67 and TGF-ß1 by immunohistochemistry, detection of 5α-reductase activity by ELISA, and measurement of the apoptosis index of the prostatic cells by TUNEL. RESULTS: Compared with the model controls, the mice of the other groups showed significantly reduced prostatic volume (P <0.05), prostatic index (P <0.05), expressions of FGF2, Ki67 and TGF-ß1, and activity of 5 α-reductase (P <0.05), but remarkably increased apoptosis index of the prostatic cells (P <0.05). However, no statistically significant differences were observed in the above parameters between the finasteride control and the three KR+C groups (P>0.05). CONCLUSIONS: KR+C can reduce the prostatic volume of PH mice by decreasing the activity of 5α- reductase, inhibiting the expressions of FGF2, Ki67 and TGF-ß1, and promoting the apoptosis of prostatic cells.


Subject(s)
Cinnamomum zeylanicum/chemistry , Phytotherapy/methods , Plant Roots/chemistry , Prostatic Hyperplasia/drug therapy , Pueraria/chemistry , Animals , Apoptosis , Cholestenone 5 alpha-Reductase/metabolism , Fibroblast Growth Factor 2/metabolism , Finasteride/therapeutic use , In Situ Nick-End Labeling , Ki-67 Antigen/metabolism , Male , Mice , Organ Size , Prostate/pathology , Prostatic Hyperplasia/metabolism , Prostatic Hyperplasia/pathology , Random Allocation , Testosterone Propionate/administration & dosage , Transforming Growth Factor beta1/metabolism , Urological Agents/therapeutic use
2.
National Journal of Andrology ; (12): 353-360, 2017.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-812760

ABSTRACT

Objective@#To explore the effects of Kudzu Root plus Cinnamon Granules (KR+C) on prostatic hyperplasia (PH) in mice.@*METHODS@#Sixty 4-week-old Kunming male mice were randomly divided into six groups: blank control, PH model, high-, medium- and low-dose KR+C, and finasteride control. All the mice except those in the blank control group were subcutaneously injected with testosterone propionate (5 mg / [kg·d]) at 7 days after surgical castration. The animals of different groups were treated intragastrically with different doses of KR+C, finasteride, and normal saline respectively for 3 weeks and then sacrificed for weighing of the prostate, calculation of the prostatic index, observation of the morphological changes in the prostate after HE staining, determination of the expressions of FGF2, Ki67 and TGF-β1 by immunohistochemistry, detection of 5α-reductase activity by ELISA, and measurement of the apoptosis index of the prostatic cells by TUNEL.@*RESULTS@#Compared with the model controls, the mice of the other groups showed significantly reduced prostatic volume (P 0.05).@*CONCLUSIONS@#KR+C can reduce the prostatic volume of PH mice by decreasing the activity of 5α- reductase, inhibiting the expressions of FGF2, Ki67 and TGF-β1, and promoting the apoptosis of prostatic cells.


Subject(s)
Animals , Male , Mice , Apoptosis , Cholestenone 5 alpha-Reductase , Metabolism , Cinnamomum zeylanicum , Chemistry , Fibroblast Growth Factor 2 , Metabolism , Finasteride , Therapeutic Uses , In Situ Nick-End Labeling , Ki-67 Antigen , Metabolism , Organ Size , Phytotherapy , Methods , Plant Roots , Chemistry , Prostate , Pathology , Prostatic Hyperplasia , Drug Therapy , Metabolism , Pathology , Pueraria , Chemistry , Random Allocation , Testosterone Propionate , Transforming Growth Factor beta1 , Metabolism , Urological Agents , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL
...